Methods-writing week is not the moment to discover that a reconstitution step lives only in someone’s memory. The record needs to be precise enough for a colleague to repeat an in-vitro preparation, while staying clearly inside research-use-only boundaries. Research materials are not medicines, medical devices, injectables, treatments or food supplements, and they are not for human or veterinary use. The aim is a defensible laboratory method: source materials identified, calculations traceable, handling conditions stated, and batch documentation attached.
Set the Scope Before You Write the Procedure
Define the in-vitro purpose and the stopping point
A repeatable reconstitution record begins with scope, not prose. State that the step prepares a stock or working concentration for a named in-vitro assay. Identify the assay, the laboratory, the bench or cabinet, the responsible researcher and the point at which the preparation is considered complete. Say what the reconstituted material will be used for, and what it will not be used for: it is a research-use-only laboratory reagent, not for human or veterinary use, and not for clinical, diagnostic or therapeutic application. This prevents a methods paragraph from drifting into ambiguous language that a reader cannot safely interpret.
Write each action as something a colleague can see and check. Allow the lyophilised vial and the diluent to reach ambient temperature before opening, as the shop’s handling guidance describes, then work in a clean environment and remove only the amount required for the experiment. Record the diluent identity, the intended volume, the target concentration and the calculation route. Include the order of operations: label check, vial equilibration, diluent addition, mixing technique, settling time and any visual observation. Avoid shorthand such as “as usual” or “until dissolved”; replace it with a definition from your laboratory SOP or an observable endpoint. Where a detail is not fixed by the SOP, say so and record the decision made.
The method should also name the control points that affect repeatability. Note the PPE, COSHH assessment reference, waste route and spill response that apply to the named materials. Record the storage condition before opening and after reconstitution: the FAQ guidance describes lyophilised peptides as stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light, while reconstituted material is less stable and should be kept at 2–8°C for short-term laboratory use. Avoid repeated freeze–thaw cycles. These are handling notes for in-vitro work, not instructions for administration; the purchaser remains responsible for lawful use, safe handling, storage and disposal.
Anchor the Record to the Batch, the CoA and the Arithmetic
Identify the material without relying on packaging
A colleague repeating the work needs to know which vial was used, not merely which product name appeared on an order. Record the catalogue item, product code, vial label reference and certificate of analysis for the batch. The label reference format combines SKU code and expiry date, for example BPC10-03/27, and links to the corresponding CoA; quote that reference when contacting the shop about documentation. If the source page names Research Sciences, note that the FAQ describes Research Sciences as the parent company of Imperial Peptides UK, and that some older pages may still use Imperial Sciences UK or Imperial Peptides UK wording. Record the product name and documentation exactly as they appear on the current product page and batch CoA. Do not use vial cap colour as an identity marker: the FAQ states that cap colours and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.
Attach the batch CoA and point readers to the fields they need: product name, batch or label reference, purity and identity record as published, and the testing documentation supplied for that batch. If an Internal Test Reference appears, explain it accurately: the FAQs state that restocked products may carry the same ITR as earlier stock; an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. The homepage lists “CoAs Janoshik Analytical Reports”, so if that wording matters to the methods note, quote it as the shop’s published description and instruct the repeat researcher to open and check the CoA that accompanies the specific batch. Do not copy a purity figure from a webpage into a method as though it were batch-specific; reconfirm it on the CoA.
The arithmetic deserves its own subsection. State the vial quantity, the diluent volume added, the resulting stock concentration, any dilution to working concentration and the final assay context. Keep units explicit and show one worked calculation so a colleague can audit the logic rather than reproduce a number blindly. If the laboratory uses the free reconstitution calculator described for research use only, record its inputs and outputs as a supplementary check; the calculator is not for human or veterinary dosing. When a repeat requires fresh materials, the colleague should review the current catalogue and Buy peptides only after confirming the product page, the research-use-only label and the batch CoA, then record the new batch reference without overwriting the original. This keeps the method auditable across batches.
Use Methods Week to Test the Record, Not Just Polish It
Peer review should reproduce the step on paper and at the bench
Methods-writing week is an opportunity to turn documentation into a repeatability test. Give the draft to a colleague who did not perform the original preparation and ask them to walk through it against the physical materials, the CoA and the calculation sheet. The reviewer should be able to answer four questions without asking the author: which batch was used, which diluent and volume were added, how the concentration was calculated, and where the record is stored. If any answer requires memory or a separate email, the method is not yet complete. Use a version number, author, reviewer and change note so later edits are traceable; avoid replacing an old record with a new one without preserving the original batch reference.
A useful dry run includes a deviation log. The colleague should note where they hesitated, which terms were ambiguous and which steps depended on tacit knowledge. Common fixes include replacing “mix gently” with the actual technique described in the laboratory SOP, clarifying whether the vial was equilibrated to ambient temperature before opening, and stating how the reconstituted material was labelled for short-term storage at 2–8°C. Record observations rather than assumptions: if a visual check is part of the method, say what is recorded, not what should be seen unless a validated specification exists. If the shop’s published guidance or CoA wording is used, attribute it to the current document and ask the reviewer to reconfirm it rather than treating a webpage as a permanent specification.
Before the method is signed off, check that it repeats the research-use-only boundary in plain language: materials are not for human or veterinary use, not for consumption, administration or clinical application, and the purchaser is responsible for compliance with relevant UK regulations, including COSHH and laboratory safety standards. Add the storage and disposal route, the CoA location and the label reference. The practical test is straightforward: can a competent colleague repeat the in-vitro reconstitution, calculate the concentration and locate the batch evidence without reconstructing the story from memory? If yes, the record is ready for methods week and for the next batch.
